Introduction While COVID-19 pandemic continues to spread worldwide, researchers have
linked patterns of traits to poor disease outcomes. Risk factors for COVID-19 include asthma …

The heterogeneous phenotypes among patients with coronavirus disease 2019 (COVID-19)
has drawn worldwide attention, especially those with severe symptoms without comorbid …

Recent studies suggest excessive complement activation in severe coronavirus disease-19
(COVID-19). The latter shares common characteristics with complement-mediated …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus was identified in
China in 2019 as the causative agent of COVID-19, and quickly spread throughout the …

Few studies have focused on COVID-19 patients' hepatic histopathological features. Many of
the described morphological landscapes are non-specific and possibly due to other …

The role of the mucosal pulmonary antibody response in coronavirus disease 2019 (COVID-
19) outcome remains unclear. Here, we found that in bronchoalveolar lavage (BAL) samples …

Fc‐gamma receptor (FcγR) activation by soluble IgG immune complexes (sICs) represents a
major mechanism of inflammation in certain autoimmune diseases such as systemic lupus …

Therapeutic plasma exchange (TPE) has been proposed as a rescue therapy in critically ill
COVID‑19 patients. The aim of the present study was to determine whether combining TPE …

Аннотация За время пандемии появилось большое число работ, посвященных COVID-
инфекции, позволивших достаточно глубоко понять патогенетические особенности …

ABSTRACT SARS-like coronavirus (SARS-CoV2) has emerged as a global threat to
humankind and is rapidly spreading. The infectivity, pathogenesis and infection of this virus …